Fibre-optic probe to fight cancer:
This article was originally published in Clinica
UK researchers have developed a fibre-optic probe which tells doctors which cancers can be treated with radiotherapy and which will resist. The £17,000 ($27,000) device, called Oxylite, measures the amount of oxygen in a tumour - the more oxygen present, the easier it is to kill the tumour with radiotherapy. The researchers, from the Cancer Research Campaign Advanced Technology Group in London, said the device has wider applications in plastic surgery, head injuries, shock and heart treatments.
You may also be interested in...
Teva plans to begin appeal proceedings, the firm has told Generics Bulletin, after being fined €60.5m ($72m) by the European Commission over an historic “pay-for-delay” arrangement covering subsidiary firm Cephalon’s Provigil (modafinil).
SK set for Korean trial with vaccine, as Biological E begins human trials of Baylor vaccine. Meanwhile, DongWha gets a Phase II nod for potential drug, and Celltrion progesses with Phase II regdanvimab trial.
UK start up Iceni Diagnostics has secured funding to develop its test for the live, intact SARS-CoV-2 virus and the UK government is evaluating a lateral flow device based on the technology for testing saliva samples as part of efforts to step up rapid testing in the country.